Home › COPD
Pag-aaral pangklinika para sa COPD na nagre-recruit sa U.S.
100 pag-aaral para sa COPD ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Philadelphia, PA26 pag-aaral
- Miami, FL20 pag-aaral
- Houston, TX18 pag-aaral
- Birmingham, AL17 pag-aaral
- Baltimore, MD16 pag-aaral
- Boston, MA15 pag-aaral
- Orlando, FL15 pag-aaral
- Chicago, IL15 pag-aaral
- Dallas, TX13 pag-aaral
- New York City, NY12 pag-aaral
- Pittsburgh, PA11 pag-aaral
- Winston-Salem, NC11 pag-aaral
- Hialeah, FL10 pag-aaral
- Ann Arbor, MI10 pag-aaral
- Charlotte, NC10 pag-aaral
- Detroit, MI9 pag-aaral
- Phoenix, AZ9 pag-aaral
- Nashville, TN9 pag-aaral
- Los Angeles, CA9 pag-aaral
- Columbus, OH9 pag-aaral
- Kansas City, KS9 pag-aaral
- Milwaukee, WI8 pag-aaral
- Newport Beach, CA8 pag-aaral
- Cleveland, OH8 pag-aaral
- Tampa, FL8 pag-aaral
- West Palm Beach, FL8 pag-aaral
- Kendall, FL7 pag-aaral
- McKinney, TX7 pag-aaral
- St. Louis, MO7 pag-aaral
- Denver, CO7 pag-aaral
- Savannah, GA7 pag-aaral
- Indianapolis, IN6 pag-aaral
- Camden, NJ6 pag-aaral
- St. Petersburg, FL6 pag-aaral
- Atlanta, GA6 pag-aaral
- Shreveport, LA6 pag-aaral
- Aurora, CO6 pag-aaral
- Spartanburg, SC6 pag-aaral
- Las Vegas, NV6 pag-aaral
- Farmington Hills, MI6 pag-aaral
Ayos sa estado
- Alabama20 pag-aaral
- Arizona17 pag-aaral
- California27 pag-aaral
- Colorado15 pag-aaral
- Connecticut4 pag-aaral
- Florida31 pag-aaral
- Georgia14 pag-aaral
- Idaho4 pag-aaral
- Illinois20 pag-aaral
- Indiana11 pag-aaral
- Iowa6 pag-aaral
- Kansas13 pag-aaral
- Kentucky5 pag-aaral
- Louisiana10 pag-aaral
- Maine3 pag-aaral
- Maryland18 pag-aaral
- Massachusetts24 pag-aaral
- Michigan23 pag-aaral
- Minnesota11 pag-aaral
- Mississippi3 pag-aaral
- Missouri10 pag-aaral
- Montana3 pag-aaral
- Nebraska5 pag-aaral
- Nevada9 pag-aaral
- New Jersey8 pag-aaral
- New York23 pag-aaral
- North Carolina24 pag-aaral
- Ohio18 pag-aaral
- Oklahoma9 pag-aaral
- Oregon7 pag-aaral
- Pennsylvania33 pag-aaral
- South Carolina17 pag-aaral
- South Dakota7 pag-aaral
- Tennessee16 pag-aaral
- Texas28 pag-aaral
- Utah7 pag-aaral
- Vermont5 pag-aaral
- Virginia12 pag-aaral
- Washington8 pag-aaral
- West Virginia5 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07780669Digital Inhaler Use in Obstructive Lung Disease Care
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07214337A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07780656Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07686302A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07725939Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07874815A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Nagre-recruitPhase 2
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07759245Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07051707WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07558265Rademikibart IV for Acute Asthma and COPD Exacerbation
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07705737A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07908381To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Nagre-recruitPhase 2
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07684820Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
Nagre-recruit
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT05572632Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Nagre-recruitPhase 4
Edad 19 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07135427A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07555483A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07646587Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT01776398A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Nagre-recruitPhase 4
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07053423Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
Nagre-recruitPhase 4
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07133880Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Nagre-recruit
Edad 40 hanggang 84 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07190209The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06524856Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.